Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
LOLA and Plasma Exchange in Pediatric Acute Liver Failure
NCT05778461Unknown
- Sponsor
- Institute of Liver and Biliary Sciences
- Start
- Mar 2023
- Primary completion
- Oct 2024
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Randomised, double-blind trial in Acute Liver Failure (ALF) comparing L-ornithine L-Aspartate with Placebo (2 arms). Primary endpoint: Comparison of change in ammonia (baseline to day 3). Status: unknown.
02
Drugs
l-ornithine l-aspartate
03
Conditions
Acute Liver Failure (ALF)
Beyond the preview
Go deeper on NCT05778461.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05778461.